Lymphoma Of B Cell Origin clinical trials

Explore recruiting lymphoma of b cell origin clinical trials.

Also recruiting in Europe

Lymphoma Of B Cell Origin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

Finland, Spain, Denmark, Poland, Germany, France +3 more

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Combination With Other Agents in Subjects With B-cell Non-Hodgkin Lymphoma

Spain, Sweden, Italy, Belgium, Finland, France +4 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Lymphoma Of B Cell Origin trials by city

Lymphoma Of B Cell Origin in Toronto Lymphoma Of B Cell Origin in Vancouver Lymphoma Of B Cell Origin in Montreal Lymphoma Of B Cell Origin in Calgary Lymphoma Of B Cell Origin in Edmonton Lymphoma Of B Cell Origin in Ottawa Lymphoma Of B Cell Origin in Winnipeg Lymphoma Of B Cell Origin in Quebec City Lymphoma Of B Cell Origin in Hamilton Lymphoma Of B Cell Origin in Kitchener Lymphoma Of B Cell Origin in London Lymphoma Of B Cell Origin in Halifax Lymphoma Of B Cell Origin in New York Lymphoma Of B Cell Origin in Los Angeles Lymphoma Of B Cell Origin in Chicago Lymphoma Of B Cell Origin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease